Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Protara Therapeutics, Inc. (TARA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-21.67M |
|
-- |
|
-- |
|
$23.32M |
|
$-23.32M |
|
$1.66M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-23.32M |
|
$-23.70M |
|
61.01M |
|
61.01M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$146.15M |
|
$1.32M |
|
$29.94M |
|
$176.09M |
|
$13.32M |
|
-- |
|
$1.46M |
|
$14.78M |
|
$161.31M |
|
$161.31M |
|
$161.31M |
|
59.08M |
|
| Cash Flow Statement Financials | |
$-36.73M |
|
$3.03M |
|
$1.12M |
|
$50.40M |
|
$17.82M |
|
$-32.58M |
|
$2.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.97 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.43% |
|
-13.43% |
|
-12.30% |
|
-13.43% |
|
$2.73 |
|
$-0.61 |
|
$-0.60 |
|